Optimizing the Management of Inherited Blood Disorders
This webinar was recorded on Jan. 25, 2023
Sponsored by BioMarin and CSL Behring.
This webinar featured a candid conversation with panelists from AMCP’s Market Insights Roundtable on Optimizing the Management of Inherited Blood Disorders. Speakers will provide an overview of the current and evolving coverage and treatment landscapes for Hemophilia, Sickle Cell, and Beta Thalassemia.
Speakers will share insights from the roundtable discussion which included first-hand patient testimonials, best-in-class treatment pathways, as well as concerns relative to real-world evidence, value determination, affordability, and variations in approaches to coverage. Participants recognized the need for evolution in policy, regulations, and business operations in order to enable patient access to emerging therapies.
- Wendy Bailey
VP of Health Plan Pharmacy Strategy
Centene Pharmacy Services
- Sal Morana
EVP, Pharmacy Practice Lead - Hospitals & Health Systems
Alliant Employee Benefits